{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:59:59Z","timestamp":1780379999647,"version":"3.54.1"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T00:00:00Z","timestamp":1402012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0098232","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T20:23:39Z","timestamp":1402086219000},"page":"e98232","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["The Effect of Lithospermic Acid, an Antioxidant, on Development of Diabetic Retinopathy in Spontaneously Obese Diabetic Rats"],"prefix":"10.1371","volume":"9","author":[{"given":"Cheng Ji","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Chul","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJM199505043321807","article-title":"Prevention and treatment of the complications of diabetes mellitus","volume":"332","author":"CM Clark Jr","year":"1995","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dmr.5610050703","article-title":"The Wisconsin epidemiological study of diabetic retinopathy: a review","volume":"5","author":"R Klein","year":"1989","journal-title":"Diabetes Metab Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00006982-199707000-00008","article-title":"Clinicopathologic correlation of intraretinal microvascular abnormalities","volume":"17","author":"PD Imesch","year":"1997","journal-title":"Retina"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/bjo.77.9.574","article-title":"Ultrastructure of retinal vessels in diabetic patients","volume":"77","author":"T Ishibashi","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1463-1326.2011.01415.x","article-title":"New approaches to the treatment of diabetic retinopathy","volume":"13","author":"M Porta","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2012.03.013","article-title":"Fenofibrate \u2013 a potential systemic treatment for diabetic retinopathy?","volume":"154","author":"TY Wong","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2","volume":"117","author":"M Michaelides","year":"2010","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study","volume":"33","author":"P Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2005.06.007","article-title":"A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema","volume":"112","author":"ET Cunningham Jr","year":"2005","journal-title":"Ophthalmology"},{"key":"ref11","first-page":"1","article-title":"Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats","volume":"7","author":"Y Lu","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"ref12","first-page":"1153","article-title":"Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes","volume":"41","author":"FC Barouch","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"K Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1167\/iovs.11-7784","article-title":"Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects","volume":"52","author":"SJ Woo","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"LP Aiello","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0140-6736(05)62099-5","article-title":"Vascular endothelial growth factor in diabetic retinopathy","volume":"349","author":"Y Tanaka","year":"1997","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmet.2012.11.012","article-title":"Vascular complications of diabetes: mechanisms of injury and protective factors","volume":"17","author":"C Rask-Madsen","year":"2013","journal-title":"Cell Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.11.001","article-title":"Dietary antioxidants in preventing atherogenesis","volume":"187","author":"AC Kaliora","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0306-3623(94)90011-6","article-title":"Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat","volume":"25","author":"K Kamata","year":"1994","journal-title":"Gen Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1211\/0022357021891","article-title":"Peroxynitrite scavenging activity of lithospermate B from Salvia miltiorrhiza","volume":"55","author":"DY Soung","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2011.01.018","article-title":"Lithospermic acid B protects beta-cells from cytokine-induced apoptosis by alleviating apoptotic pathways and activating anti-apoptotic pathways of Nrf2-HO-1 and Sirt1","volume":"252","author":"BW Lee","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.ASN.0000051660.82593.19","article-title":"Delayed treatment with lithospermate B attenuates experimental diabetic renal injury","volume":"14","author":"GT Lee","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2008.02.072","article-title":"Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury","volume":"586","author":"KY Hur","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2010.01.035","article-title":"Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway","volume":"211","author":"KY Hur","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/157339910793360815","article-title":"Angiogenic growth factors and their inhibitors in diabetic retinopathy","volume":"6","author":"A Praidou","year":"2010","journal-title":"Curr Diabetes Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1167\/iovs.12-10553","article-title":"ERK5 Regulates glucose-induced increased fibronectin production in the endothelial cells and in the retina in diabetes","volume":"53","author":"Y Wu","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"F Giacco","year":"2010","journal-title":"Circ Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ab.2008.09.014","article-title":"Neopterin, a marker of immune response, and 8-hydroxy-2\u2032-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine","volume":"383","author":"P Svoboda","year":"2008","journal-title":"Anal Biochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/112067210801800116","article-title":"Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients","volume":"18","author":"QY Dong","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2337\/diabetes.50.12.2837","article-title":"Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats","volume":"50","author":"KS Park","year":"2001","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1248\/cpb.50.1135","article-title":"Effective isolation of magnesium lithospermate B and its inhibition of aldose reductase and fibronectin on mesangial cell line","volume":"50","author":"M Jung","year":"2002","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00592-012-0449-3","article-title":"Pathophysiology and treatment of diabetic retinopathy","volume":"50","author":"F Bandello","year":"2013","journal-title":"Acta Diabetol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"DA Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","article-title":"Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage","volume":"59","author":"J Wang","year":"2010","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"LP Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)65044-4","article-title":"Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)","volume":"156","author":"K Miyamoto","year":"2000","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"DW Leung","year":"1989","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1076\/ceyr.28.4.251.27834","article-title":"Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats","volume":"28","author":"X Xu","year":"2004","journal-title":"Curr Eye Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1167\/iovs.06-0322","article-title":"VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability","volume":"47","author":"NS Harhaj","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.phrs.2007.04.016","article-title":"The role of protein kinase C activation and the vascular complications of diabetes","volume":"55","author":"EN Das","year":"2007","journal-title":"Pharmacol Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1755-3768.2010.02010.x","article-title":"Treatment of diabetic retinopathy with anti-VEGF drugs","volume":"89","author":"M Waisbourd","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1167\/iovs.04-1361","article-title":"Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes","volume":"46","author":"RA Feit-Leichman","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1167\/iovs.12-11309","article-title":"Retinal Neurodegeneration in Type II Diabetic Otsuka Long-Evans Tokushima Fatty Rats","volume":"54","author":"JH Yang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.2052","article-title":"Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy","volume":"15","author":"P Geraldes","year":"2009","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/diabetes.52.5.1229","article-title":"Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats","volume":"52","author":"S Roy","year":"2003","journal-title":"Diabetes"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3109\/02713683.2010.514659","article-title":"Vascular basement membrane thickening in diabetic retinopathy","volume":"35","author":"S Roy","year":"2010","journal-title":"Curr Eye Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","article-title":"Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics","volume":"339","author":"LL Wu","year":"2004","journal-title":"Clin Chim Acta"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000050900","article-title":"Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy","volume":"215","author":"Y Mitamura","year":"2001","journal-title":"Ophthalmologica"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00125-005-1799-y","article-title":"Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study","volume":"48","author":"MV van Hecke","year":"2005","journal-title":"Diabetologia"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jdiacomp.2005.04.002","article-title":"High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells","volume":"19","author":"N Makino","year":"2005","journal-title":"J Diabetes Complications"},{"key":"ref51","first-page":"1586","article-title":"Soluble TNF receptors in vitreoretinal proliferative disease","volume":"42","author":"GA Limb","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/jpet.113.203067","article-title":"Neuroprotective effects of cilostazol on retinal ganglion cell damage in diabetic rats","volume":"345","author":"KI Jung","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/db07-1431","article-title":"Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway","volume":"57","author":"YH Kim","year":"2008","journal-title":"Diabetes"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0021-5155(02)00631-7","article-title":"Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat) \u2013 possibility of a new experimental model for diabetic retinopathy","volume":"47","author":"ZY Lu","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/0126839-200809001-00003","article-title":"Ocular disorders secondary to systemic disease and the potential role of carnitines","volume":"9","author":"N Pescosolido","year":"2008","journal-title":"Drugs R D"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/dia.2011.0172","article-title":"Oxidative stress in preretinopathic diabetes subjects and antioxidants","volume":"14","author":"M Nebbioso","year":"2012","journal-title":"Diabetes Technol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0098232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T10:01:28Z","timestamp":1565517688000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0098232"}},"subtitle":[],"editor":[{"given":"Ramani","family":"Ramchandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0098232","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,6]]}}}